EN-US Sat, 25 May 2013 19:52:31 -0400 248216 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wNO6sg4BFl0/initiating-coverage-of-amarantus-credibility-vs-perception-analyst-blog-cm248216 Investing Business Stocks Today, I am initiating coverage of Amarantus BioScience Holdings, Inc. (OTC: AMBS ) with a 'Neutral' rating and $0.25 price target. Yes, a 'Neutral' rating. Neutral based primarily on the<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/wNO6sg4BFl0" height="1" width="1"/> Thu, 23 May 2013 20:27:49 Z 2013-05-23T17:34:11Z Jason Napodano AMBS http://www.nasdaq.com/article/initiating-coverage-of-amarantus-credibility-vs-perception-analyst-blog-cm248216